Search

Author/Creator Shubin, Richard

1. A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. (March 2021)

Authors:
Fox, Edward; Lovett-Racke, Amy E; Gormley, Matthew; Liu, Yue; Petracca, Maria; Cocozza, Sirio; Shubin, Richard; Wray, Sibyl; Weiss, Michael S; Bosco, Jenna A; Power, Sean A; Mok, Koby; Inglese, Matilde
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 3(2021)
Page Start:
420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies. (March 2022)

Authors:
Rascol, Olivier; Tönges, Lars; deVries, Tina; Jaros, Mark; Quartel, Adrian; Jacobs, David; Azulay, Jean-Philippe; Balaguer, Ernest; Bhatia, Perminder; Bodis-Wollner, Ivan; Brownstone, Paul; Boulloche, Nicolas; Calegan, Gerald J.; Castelnovo, Giovanni; Chou, Kelvin L.; Corvol, Jean-Christophe; Dan...
Journal:
Parkinsonism & related disorders
Issue:
Volume 96(2022)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Prospective, Multicenter, Randomized, Double‐Blinded, Partial Crossover Study to Assess the Safety and Efficacy of the Novel Neuromodulation System in the Treatment of Patients With Chronic Pain of Peripheral Nerve Origin. Issue 1 (22nd January 2016)

Authors:
Deer, Timothy; Pope, Jason; Benyamin, Ramsin; Vallejo, Ricardo; Friedman, Andrew; Caraway, David; Staats, Peter; Grigsby, Eric; Porter McRoberts, W.; McJunkin, Tory; Shubin, Richard; Vahedifar, Payam; Tavanaiepour, Daryoush; Levy, Robert; Kapural, Leonardo; Mekhail, Nagy
Journal:
Neuromodulaton
Issue:
Volume 19:Issue 1(2016)
Page Start:
91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗